Search Results

Mutations in the 3'-PPT Lead to HIV-1 Replication without Integration.

• Authors : Richetta C; LBPA, ENS Paris-Saclay, CNRS UMR8113, IDA FR3242, Université Paris-Saclay, Cachan, France.; Subra F

Subjects: DNA, Viral*/DNA, Viral*/DNA, Viral*/genetics ; HIV-1*/HIV-1*/HIV-1*/genetics ; Mutation*

• Source: Journal of virology [J Virol] 2022 Jul 27; Vol. 96 (14), pp. e0067622. Date of Electronic Publication: 2022 Jun 27.Publisher: American Society For Microbiology Country of Publication: United States NLM ID: 0113724 Publication Model: Print-Electronic Cited Medium:

Record details

HIVfird: A Tool for Detection of Resistance to Fusion Inhibitor Drugs in HIV-1 Sequences.

• Authors : Barreto Vasconcelos AL; Department of Biochemistry and Biophysics, Federal University of Bahia, Salvador, Brazil.; Monteiro-Cunha JP

Subjects: Drug Resistance, Viral*/Drug Resistance, Viral*/Drug Resistance, Viral*/genetics ; Mutation* ; Software*

• Source: AIDS research and human retroviruses [AIDS Res Hum Retroviruses] 2019 Oct; Vol. 35 (10), pp. 941-947. Date of Electronic Publication: 2019 Aug 12.Publisher: Mary Ann Liebert Country of Publication: United States NLM ID: 8709376 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

An apparent paradox: resistance mutations in HIV-1 DNA predict improved virological responses to antiretroviral therapy.

• Authors : Geretti AM; Institute of Infection & Global Health, University of Liverpool, Liverpool, UK.; Abdullahi A

Subjects: Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*therapeutic use ; DNA, Viral/DNA, Viral/DNA, Viral/*genetics ; Drug Resistance, Viral/Drug Resistance, Viral/Drug Resistance, Viral/*genetics

• Source: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2019 Oct 01; Vol. 74 (10), pp. 3011-3015.Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print Cited Medium: Internet ISSN:

Record details

The outcome of HIV-positive late presenters according to detectable CMV DNA and anti-CMV treatment.

• Authors : Bigliano P; Unit of Infectious Diseases, Department of Medical Sciences, University of Turin, Turin, Italy.; Calcagno A

Subjects: AIDS-Related Opportunistic Infections/AIDS-Related Opportunistic Infections/AIDS-Related Opportunistic Infections/*drug therapy ; Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use ; Cytomegalovirus/Cytomegalovirus/Cytomegalovirus/*drug effects

• Source: Antiviral therapy [Antivir Ther] 2018; Vol. 23 (5), pp. 451-456.Publisher: SAGE Publications Country of Publication: England NLM ID: 9815705 Publication Model: Print Cited Medium: Internet ISSN: 2040-2058

Record details

University of Oxford Researcher Provides New Study Findings on HIV/AIDS Vaccines (New vector and vaccine platforms: mRNA, DNA, viral vectors).

• Source: Vaccine Weekly; 1/1/2024, p137-137, 1p

Record details

Trends in hepatitis B virus resistance to nucleoside/nucleotide analogues in North China from 2009-2016: A retrospective study.

• Authors : Guo X; Beijing You An Hospital, Capital Medical University, Beijing 100069, China; Beijing Institute of Hepatology, Beijing 100069, China

Subjects: Mutation*; Antiviral Agents/Antiviral Agents/Antiviral Agents/*pharmacology ; DNA, Viral/DNA, Viral/DNA, Viral/*genetics

• Source: International journal of antimicrobial agents [Int J Antimicrob Agents] 2018 Aug; Vol. 52 (2), pp. 201-209. Date of Electronic Publication: 2018 Apr 12.Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 9111860 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Novel HBV mutations and their value in predicting efficacy of conventional interferon.

• Authors : Wu DX; Department of Infectious Diseases, Xiangya Hospital, Central South University, Key Laboratory of Viral Hepatitis of Hunan Province, Changsha, China. .; Fu XY

Subjects: Mutation*; Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use ; DNA, Viral/DNA, Viral/DNA, Viral/*genetics

• Source: Hepatobiliary & pancreatic diseases international : HBPD INT [Hepatobiliary Pancreat Dis Int] 2017 Apr; Vol. 16 (2), pp. 189-196.Publisher: Elsevier Country of Publication: Singapore NLM ID: 101151457 Publication Model: Print Cited Medium: Internet ISSN: 1499-3872 (Print)

Record details

Occult hepatitis B virus infection and S gene escape mutants in HIV-infected patients after hepatitis B virus vaccination.

• Authors : Aghakhani A; Clinical Research Department, Pasteur Institute of Iran, Tehran, Iran.; Mohraz M

Subjects: DNA, Viral/DNA, Viral/DNA, Viral/*blood ; Genes, Viral/Genes, Viral/Genes, Viral/*genetics ; HIV Infections/HIV Infections/HIV Infections/*complications

• Source: International journal of STD & AIDS [Int J STD AIDS] 2016 Oct; Vol. 27 (11), pp. 967-72. Date of Electronic Publication: 2015 Sep 18.Publisher: Sage Country of Publication: England NLM ID: 9007917 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1758-1052

Record details

High prevalence of HIV-1 transmitted drug-resistance mutations from proviral DNA massively parallel sequencing data of therapy-naïve chronically infected Brazilian blood donors.

• Authors : Pessôa R; Laboratory of Dermatology and Immunodeficiencies, Department of Dermatology, Tropical Medicine Institute of São Paulo, University of São Paulo, São Paulo, Brazil.; Sanabani SS

Subjects: Blood Donors* ; Mutation*; DNA, Viral/DNA, Viral/DNA, Viral/*genetics

• Source: PloS one [PLoS One] 2017 Sep 27; Vol. 12 (9), pp. e0185559. Date of Electronic Publication: 2017 Sep 27 (Print Publication: 2017).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

Distinctive Drug-resistant Mutation Profiles and Interpretations of HIV-1 Proviral DNA Revealed by Deep Sequencing in Reverse Transcriptase.

• Authors : Yin QQ; State Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention (NCAIDS), Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing 102206, China.; Li ZP

Subjects: Antiviral Agents/Antiviral Agents/Antiviral Agents/*pharmacology ; DNA, Viral/DNA, Viral/DNA, Viral/*genetics ; Drug Resistance, Viral/Drug Resistance, Viral/Drug Resistance, Viral/*genetics

• Source: Biomedical and environmental sciences : BES [Biomed Environ Sci] 2016 Apr; Vol. 29 (4), pp. 239-47.Publisher: Chinese Center for Disease Control and Prevention Country of Publication: China NLM ID: 8909524 Publication Model: Print Cited Medium: Print

Record details